Evidence map›Paper›PMID 35015303›Full record

ArticleAmerican journal of hematology2022

BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study.

Xin Rong Lim, Bernard PuiLam Leung, Christina Lai Lin Sum, Gek Hsiang Lim, Choon Guan Chua, Tian Ming Tu, Kollengode Ramanathan, Mei Yan Huang, Hwee Siew Howe, Bingwen Eugene Fan

Open access · greenAbstract readLetter
In one paragraph

Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xin Rong LimDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore.
Bernard PuiLam LeungDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore.
Christina Lai Lin SumDepartment of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Gek Hsiang LimClinical Research and Innovation Office, Tan Tock Seng Hospital, Singapore.
Choon Guan ChuaDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore.
Tian Ming TuLee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Kollengode RamanathanYong Loo Lin School of Medicine, National University of Singapore, Singapore.
Mei Yan HuangHealth and Social Sciences, Singapore Institute of Technology, Singapore.
Hwee Siew HoweDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore.
Bingwen Eugene FanLee Kong Chian School of Medicine, Nanyang Technological University, Singapore.ORCID 0000-0003-4367-5182
National University of Singapore · SGTan Tock Seng Hospital · SGSingapore Institute of Technology · SG

Funding

National Healthcare Group-National Centre for Infectious Diseases (NHG-NCID) COVID-19 Centre Grant FY2021LXR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ThrombophiliaAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesHumansLongitudinal StudiesProspective StudiesRNA, MessengerSARS-CoV-2Up-RegulationVaccinationAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID35015303
PMCPMC9011698
OpenAlexW4206088132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.